• Study suggests SARS-CoV-2 could affect aquatic wildlife

    1 day ago - By News Medical

    Researchers have found that oxidative stress and neurotoxicity biomarkers increased in tadpoles exposed to synthetic SARS-CoV-2 spike protein peptides.
    Read more ...

     

  • New tests may help reveal the transcriptome of SARS-CoV-2 and predict disease course

    1 day ago - By News Medical

    As the COVID-19 pandemic continues to infect people in their hundreds of thousands around the world, a new study describes a panel of novel tests for genomic and subgenomic mRNAs generated by SARS-CoV-2. Most assays in use at present are either qualitative or semi-quantitative, and cannot evaluate the transcription molecules in detail.
    Read more ...

     

  • A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

    1 day ago - By News Medical

    A new study reports the virucidal and fusion-inhibiting attributes of snake venom against the COVID-19 agent SARS-CoV-2.
    Read more ...

     

  • No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

    1 day ago - By News Medical

    Many patients with COVID-19 have shown neurological complications, leading to scientific interest in the role played by its causative pathogen, SARS-CoV-2, in brain inflammation. A new study has described the absence of neuroinflammation in cerebrospinal fluid .
    Read more ...

     

  • MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

    1 day ago - By News Medical

    A new study reports the preclinical testing of a recombinant MVA candidate vaccine against SARS-CoV-2, the agent that is causing the current COVID-19 pandemic.
    Read more ...

     

  • Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

    1 day ago - By News Medical

    The unchecked advance of COVID-19 has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: SARS-CoV-2. An encouraging new study shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus -based intranasal vector vaccine in animal studies.
    Read more ...

     

  • Just another common cold virus? Modeling SARS-CoV-2's future fade

    1 day ago - By ScienceDaily

    What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic - circulating in the general population - and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a new model.
    Read more ...